Molecule Name |
DB00271
|
DrugBank Groups |
Approved
|
Cluster No |
126
|
Smiles |
IC1(=C(NC(=O)C)C(I)=C(C(=O)O)C(=C1NC(=O)C)I)
|
Download |
mol2, pdbqt
|
TPSA |
95,5
|
Non-H Atoms |
20
|
Non-C/H Atoms |
9
|
Metal-Atoms |
0
|
Electronegative Atoms |
9
|
Stereo Centers |
0
|
Rotatable Bonds |
3
|
Rings Closures |
1
|
Small Rings |
1
|
Aromatic Rings |
1
|
Aromatic Atoms |
6
|
sp3-Atoms |
3
|
Symmetric atoms |
7
|
cLogS |
-5,361
|
MW |
613,902
|
cLogP |
1,8634
|
HBA |
6
|
HBD |
3
|
Ro5 violations |
1
|
Druglikeness |
1,1157
|
DrugScore |
0,218529761144107
|
Mutagenic |
high
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA-
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,6075
|
Caco-2 Permeability 2 |
0,78
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,498
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,3796
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
1,9136
|
Carcinogenicity (Three-class) |
Non-required
|